Endometrioid adenocarcinoma arising from adenomyosis: A case report and literature review;Adénocarcinome endométrioïde résultant de foyers d'adénomyose: À propos d'un cas et revue de la littérature

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 33, Issue 2, 2004, Pages 140-144

  Rubod, C ^a   Narducci, F ^a   Delattre, C ^b   Decocq, J ^a   Verbert, A ^b   Delahousse, G ^a  

^a CENTRE HOSPITALIER DE ROUBAIX   (France)

^b Hopital Victor Provo   (France)

Author keywords

Adenomyosis; Endometrioid adenocarcinoma; Hormonal replacement therapy; Oestrogen

Indexed keywords

ESTROGEN;

ADENOMYOSIS; ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; ENDOMETRIOSIS; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; PROGNOSIS; REVIEW;

EID: 1842503112     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(04)96413-7     Document Type: Review

References (32)

1. Takai N, Akizuki S, Nasu K, Etoh Y, Miyakawa I. Endometrioid adenocarcinoma arising from adenomyosis. Gynecol Obstet Invest 1999; 48: 141-4.
2. Sampson J. Endometrial carcinoma of the ovary arising in endometrial tissue in that organ. Arch Surg 1925; 10: 1-72.
3. Sasaki T, Sugiyama T, Nanjo H, Hoshi N, Murakami M, Sugita A et al. Endometrioid adenocarcinoma arising from adenomyosis: report and immunohistochemical analysis of an unusual case. Pathol Int 2001; 51: 308-13.
4. Kawana K, Shirai T, Jimbo H, Yoshida M, Takahashi M, Shiromizu K et al. Endometrial cytology in early diagnosis of adenocarcinoma arising from adenomyosis uteri. Acta Cytol 2002; 46: 612-4.
5. Ichikawa Y, Takano K, Higa S, Tanabe M, Wada A, Sugita M et al. Endometrial carcinoma coexisting with pregnancy, presumed to derive from adenomyosis: a case report. Int J Gynecol Cancer 2001; 11: 488-90.
6. Koshiyama M, Suzuki A, Ozawa M, Fujita K, Sakakibara A, Kawamura M et al. Adenocarcinomas arising from uterine adenomyosis: a report of four cases. Int J Gynecol Pathol 2002; 21: 239-45.
7. Hirai M, Hirono M, Oosaki T, Hayashi Y, Yoshihara T, Matsuzaki O. Prognostic factors relating to survival in uterine endometrioid carcinoma. Int J Gynecol Obstet 1999; 66: 155-62.
8. Srodon M, Klein W, Kurman R. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis. Am J Surg Pathol 2003; 27: 786-9.
9. Marcus C. Relationship of adenomyosis uteri to endometrial hyperplasia and endometrial carcinoma. Am J Obstet Gynecol 1961; 82: 408-16.
10. Jones K, Owen E, Berresford A, Sutton C. Endometrial andenocarcinoma arising from endometriosis of the rectosigmoid colon. Gynecol Oncol 2002; 86: 220-2.
11. Maguire P, Barney J. Endometrioid carcinoma arising in endometriosis after 21 years: a case report. J Okla State Med Assoc 1991; 84: 570-1.
12. Granai C, Walters M, Safaii H, Jelen I, Modoc-Jones H, Moukhtar M. Malignant transformation of vaginal endometriosis. Obstet Gynecol 1984; 64: 592-5.
13. Zanetta G, Webb M, Li H, Keeney G. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol 2000; 79: 18-22.
14. McCluggage W, Bryson C, Lamki H, Boyle D. Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy. Int J Gynecol Pathol 2000; 19: 276-9.
15. Okugawa K, Hirakawa T, Ogawa S, Kaku T, Nakano H. Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer. A case report. Gynecol Oncol 2002; 871: 231-4.
16. Vaccarello L, Apte S, Copeland L, Boutselis J, Rubin S. Endometrial carcinoma associated with pregnancy: a report of three cases and review of the literature. Gynecol Oncol 1999; 74: 118-22.
17. Parazzini F, Negri E, La Vecchia C, Benzi G, Chiaffarino F, Polatti A et al. Role of reproductive factors on the risk of endometrial cancer. Int J Cancer 1998; 76: 784-6.
18. Albrektsen G, Heuch I, Tretli S, Kvale G. Is the risk of cancer of the corpus uteri reduced by a recent pregnancy? A prospective study of 765, 756 norwegian women. Int J Cancer 1995; 61: 485-90.
19. Kodama J, Yoshinouchi M, Miyagi Y, Kobashi Y, Kamimura S, Okuda H et al. Advanced endometrial cancer detected at 7 months after childbirth. Gynecol Oncol 1997; 64: 501-6.
20. Taskin M, Lallas T, Shevchuk M, Barber H. p53 expression in adenomyosis in endometrial carcinoma patients. Gynecol Oncol 1996; 62: 241-6.
21. Yamauchi N, Sakamoto A, Uozaki H, Lihara K, Machinami R. Immunohistochemical analysis of endometrial adenocarcinoma for bcl-2 and p53 in relation to expression of sex steroid receptor and proliferative activity. Int J Gynecol Pathol 1996; 15: 202-8.
22. Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer 2002; 94: 2935-40.
23. Athanassiadou P, Petrakakou E, Liossi A, Nakopoulou L, Zerva C, Dimopoulos A et al. Prognostic significance of p53, bcl-2 and EGFR in carcinoma of the endometrium. Acta Cytol 1999; 43: 1039-44.
24. Chambers, J, Carcangiu M, Voynick, I, Schwartz P. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: correlation between biochemical and immunohistochemical methods and survival. Am J Clin Pathol 1990; 94: 255-60
25. Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Gynecol Oncol 1998; 69: 220-5.
26. Woodruff J, Erozan Y, Genadry R. Adenocarcinoma arising in adenomyosis detected by atypical cytology. Obstet Gynecol 1986; 67: 145-8.
27. Heaps J, Nieberg R, Berek J. Malignant neoplasms arising in endometriosis. Obstet Gynecol 1990; 75: 1023-8.
28. Magtibay P, Heppell J, Leslie K. Endometriosis associated invasive adenocarcinoma involving the rectum in a postmenopausal female: report of a case. Dis Col Rect 2001; 44: 1530-3.
29. Robbins M, Sunshine T. Metastatic carcinoide diagnosed at laparoscopic excision of pelvic endometriosis. J Am Assoc Gynecol Laparo 2000; 7: 251-3.
30. Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Zhou J et al. Role of aromatase in endometrial disease. J Steroid Biochem Mol Biol 2001; 79: 19-25.
31. Zhang S, Ye G, Chen H. The efficacity and safety of domestic luteinizing hormone-releasing hormone analogue and low dose norethindrone "add-back" therapy in the treatment of endometriosis. Zhonghua Fu Chan Ke Za Zhi 2000; 35: 482-5.
32. Huang F, Kung F, Chang S, Ty H. Effects of short-course buserelin therapy on adenomyosis. A report of two cases. J Reprod Med 2000; 45: 964-5.